Last reviewed · How we verify
NCT05802368: hemophilia
Hemophilic Knee Arthropathy Virtual Reality
NA trial testing virtual reality group in Hemophilia in 56 participants. Completed in 23 January 2023.
16 October 2022
Quick facts
| Lead sponsor | Maged Basha |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 56 |
| Start date | 10 November 2021 |
| Primary completion | 16 October 2022 |
| Estimated completion | 23 January 2023 |
| Sites | 1 location across Saudi Arabia |
Drugs / interventions tested
- virtual reality group
- exercise group
Conditions studied
- Hemophilia — all drugs for Hemophilia →
- Knee Arthropathy — all drugs for Knee Arthropathy →
Sponsor
Maged Basha
Who can join
Adults 10 to 14, male only, with Hemophilia or Knee Arthropathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study intended to examine the effect of a physical rehabilitation program incorporating Kinect-based virtual reality on gait characteristics, functional ability, and physical activity level in adolescents with hemophilic knee arthropathy.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Adolescents with hemophilic knee arthropathy can improve their gait characteristics, functional ability, and physical activity level through kinect-based virtual reality: A randomized clinical trial.
Azab AR, Elnaggar RK, Aloraini GS, Aldhafian OR, et al · · 2024 · cited 1× · PMID 38560162 · DOI 10.1016/j.heliyon.2024.e28113
Verify or expand the search:
- PubMed search for NCT05802368
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of virtual reality group
Trials testing the same drug.
- NCT06342193 — Effect of Virtual Reality Glasses on Anxiety During Cystoscopy: A Randomised Controlled Trial · NA · unknown
- NCT05982457 — The Effect of Virtual Reality Application in Cervical Dilatation and Effacement Teaching · NA · unknown
- NCT05492058 — Tactile Stimulus, Music Play and Virtual Reality Video Watching During Non-Stress Test on Maternal Anxiety and Fetal Par · NA · completed
Other recruiting trials for Hemophilia
Currently open trials in the same condition.
- NCT07579585 — Effects of Photobiomodulation in Hemophilia Patients. · NA · recruiting
- NCT07406139 — PCC Treatment for Hemophilia Patients With Inhibitor(2022PCC-A) · Phase 4 · recruiting
- NCT07285460 — A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Year · Phase 3 · recruiting
- NCT07187661 — Intra-Articular Bevacizumab for Preventing Recurrent Hemarthrosis in Hemophilia With Chronic Synovitis · NA · recruiting
- NCT07099313 — Association of Prophylactic Treatment With Treatment Burden and Psychosocial Variables in Patients With Hemophilia · recruiting
Other Maged Basha trials
Trials by the same sponsor.
- NCT05802355 — Manual Diaphragm Release in Cleaning Laborer · NA · completed
- NCT05311839 — Effect of Thera Band Exercises on Adhesive Capsulitis Post Mastectomy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05802368 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Maged Basha
- Last refreshed: 6 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05802368.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing